Repare Therapeutics
Focus: Repare Therapeutics is a Cambridge-based oncology-focused biotech company pioneering synthetic lethal therapeutics for advanced solid tumors and hematologic malignancies. The company operates as a clinical-stage developer with multiple programs in Phase 1/2 evaluation.
Profile data last refreshed Yesterday · AI intelligence enriched 1w ago
Open Jobs
0
About Repare Therapeutics
AI assessmentNot HiringNo open roles listed right now. Follow Repare Therapeutics to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
9 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
RP-6306
Adult Solid TumorRP-1664
Advanced Solid TumorClinical Trials (1)
Help build intelligence for Repare Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.